Glenview Capital Management LLC said it has no intention to acquire the hospital operator, Health Management Associates Inc (NYSE:HMA), after the latter’s recent adoption of a shareholder rights plan.
Last Friday, the Board of Directors of Delaware-based Health Management Associates Inc (NYSE:HMA) adopted a shareholder rights plan, popularly known as a poison pill, with a 15 percent trigger after the New York-based hedge fund reported in its Schedule 13D filing that it holds about 14.6 percent holding in HMA.


